[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336870-105":59,"doc-detail-336870-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","breath-test-to-detect-women-at-low-risk-for-breast-cancer-potential-clinical-and-economic-benefits","BREATH TEST TO DETECT WOMEN AT LOW RISK FOR BREAST CANCER - Potential Clinical and Economic Benefits","","A breath test using volatile organic compound biomarkers was assessed for its potential clinical and economic benefits in detecting women at low risk for breast cancer. The evaluation compared the breath test’s negative predictive value (NPV) with NPV from screening mammography. Mammography sensitivity and specificity were sourced from FDA Mammography Quality Standards Act data. Projected performance used an assumed 100,000-person asymptomatic cohort with 450/100,000 prevalence, estimating NPV and positive predictive value, alongside Medicare-based cost impact.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/breath-test-to-detect-women-at-low-risk-for-breast-cancer-potential-clinical-and-economic-benefits/336870/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/breath-test-to-detect-women-at-low-risk-for-breast-cancer-potential-clinical-and-economic-benefits/336870.png","ImageObject",300,407,{"name":92,"@type":93},"River Wang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main purpose of the breath test evaluated in this document?","Question",{"text":112,"@type":113},"To detect women at low risk for breast cancer by using biomarkers from a breath test based on volatile organic compounds, and to compare its negative predictive value with screening mammography.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were mammography performance values obtained for the comparison?",{"text":117,"@type":113},"Sensitivity and specificity values for screening mammography were taken from FDA Mammography Quality Standards Act-related amendments and regulations docket information.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the projected results and economic implication of using the breath test?",{"text":121,"@type":113},"A negative breath test identified 68.3% of the screening population as low risk, with NPV similar to mammography; Medicare reimbursement projections suggest eliminating mammography for these women could reduce annual screening costs by 38.9%.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336870,1790140893,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":19,"preview_urls":144},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","medRxiv preprint doi: [https://doi.org/10.1101/2024.10.09.24315190](https://doi.org/10.1101/2024.10.09.24315190); this version posted October 10, 2024. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.  \nIt is made available under a CC-BY-ND 4.0 International license .  \nScreening breath test for breast cancer  \nTitle: BREATH TEST TO DETECT WOMEN AT LOW RISK FOR BREAST CANCER:  \nPOTENTIAL CLINICAL AND ECONOMIC BENEFITS  \nRunning title: Breath test for low risk of breast cancer  \nAuthors: Michael Phillips (1,2)  \nTherese B Bevers (3)  \nLinda Hovanessian Larsen (4)  \nNadine Pappas (5)  \nSonali Pathak (1)  \nInstitutional affiliation for each author:  \n1. Menssana Research Inc, 1 Horizon Road, Suite 1415, Fort Lee, NJ 07024  \n2. Department of Medicine, New York Medical College, Valhalla, NY  \n3. University of Texas, MD Anderson Cancer Center, Houston, TX.  \n4. Keck Medical Center of University of Southern California, Los Angeles, CA.  \n5. Saint Michael’s Medical Center, Newark, NJ  \nContact information for each author:  \nMichael Phillips MD  [mphillips@menssanaresearch.com](mphillips@menssanaresearch.com)  \nTherese B Bevers [tbevers@mdanderson.org](tbevers@mdanderson.org)  \nLinda Hovanessian Larsen  [lhlarsen@med.usc.edu](lhlarsen@med.usc.edu)  \nNadine Pappas  [NPappas-Wilkes@primehealthcare.com](NPappas-Wilkes@primehealthcare.com)  \nSonali Pathak  [sonali.pathak9@gmail.com](sonali.pathak9@gmail.com)  \nNOTE: This preprint reports new research that has not been certifid by peer review and should not be used to guide clinical practice.  \nmedRxiv preprint doi: [https://doi.org/10.1101/2024.10.09.24315190](https://doi.org/10.1101/2024.10.09.24315190); this version posted October 10, 2024. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.  \nIt is made available under a CC-BY-ND 4.0 International license .  \nScreening breath test for breast cancer  \nCorresponding author:  \nMichael Phillips MD, FACP, FRCP  \nMenssana Research Inc,  \n1 Horizon Road, Suite 1415,  \nFort Lee, NJ 07024  \nTelephone: 201 886 3366  \n[e-mail: mphillips@menssanaresearch.com](e-mail: mphillips@menssanaresearch.com)[ ](e-mail: mphillips@menssanaresearch.com)Word count: Abstract: 348  \nText: 1,062 (excluding abstract, references and legends) Acknowledgements: Schmitt & Associates, Newark, NJ, and Michael Phillips analyzed the data. Breath test studies were funded by NIH NCI Grant Number: 5R44CA203019 – 02.  \n[ClinicalTrials.gov](ClinicalTrials.gov) Identifier: NCT02888366 .  \nConflict of Interest: Michael Phillips is President and CEO of Menssana Research, Inc. All other authors declare that they have no conflict of interest.  \nAnimals: No animals were involved.  \nEthics, reporting, and human subjects: Clinical studies were reviewed and approved by an Institutional Review Board (IRB) at all participating sites. Written informed consent was obtained from all individual participants. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.  \nmedRxiv preprint doi: [https://doi.org/10.1101/2024.10.09.24315190](https://doi.org/10.1101/2024.10.09.24315190); this version posted October 10, 2024. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.  \nIt is made available under a CC-BY-ND 4.0 International license .  \nScreening breath test for breast cancer  \nABSTRACT  \nBackground: A breath test for volatile organic compounds has identified biomarkers associated with breast cancer. We evaluated the potential ","cbCaiebUnVe3JLau","https://ap.wps.com/l/cbCaiebUnVe3JLau","pdf",313165,"English","# ABSTRACT\n## Background\n## Methods\n## Results","[{\"question\":\"What is the main purpose of the breath test evaluated in this document?\",\"answer\":\"To detect women at low risk for breast cancer by using biomarkers from a breath test based on volatile organic compounds, and to compare its negative predictive value with screening mammography.\"},{\"question\":\"How were mammography performance values obtained for the comparison?\",\"answer\":\"Sensitivity and specificity values for screening mammography were taken from FDA Mammography Quality Standards Act-related amendments and regulations docket information.\"},{\"question\":\"What were the projected results and economic implication of using the breath test?\",\"answer\":\"A negative breath test identified 68.3% of the screening population as low risk, with NPV similar to mammography; Medicare reimbursement projections suggest eliminating mammography for these women could reduce annual screening costs by 38.9%.\"}]","BREATH TEST TO DETECT WOMEN AT LOW RISK FOR BREAST CANCER - Potential Clinical and Economic Benefits | PDF",1790016921,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c118052735ebe4f7bc6f580b47f99ed8.webp",983,1272,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4688204719c72820ee4018a9984ff0c1.webp",982,1270,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e319339857f1c16730a82baadcd83ba2.webp",981,1269,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fec8a3aa7c41fad05a045112b4d7cd99.webp",980,1268]